HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Overview of attention for article published in Journal for Immunotherapy of Cancer, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 25,780 followers.

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics. https://t.co/QZ1XmIefR1

In ex vivo culture....

RT @sitcancer: #JITC Research: HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics https://t.co/ME02…

#JITC Research: HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics https://t.co/ME023PSH5k https://t.co/tUFdPsw1Kz

RT @CancerNemi: IMMUNOTHERAPY NEWS about HDAC6-selective inhibitors. Read the article ➡️ https://t.co/YnZC6sLJhW 📜 #Immunotherapy #keepcal…

New #JITC Research: HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics https://t.co/ME023PSH5k https://t.co/B725wkQf2l